Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference

WALTHAM, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Justin Renz, Chief Financial and Operations Officer, and Eric Foster, Chief Commercial Officer, will participate in a fireside chat at the Piper Sandler 36^th Annual Healthcare Conference on Wednesday, December 4, 2024 at 12:30pm EST in New York City.

Read more at globenewswire.com